555 related articles for article (PubMed ID: 27734557)
1. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras.
Gonzalez JP; Kyrychenko S; Kyrychenko V; Schneider JS; Granier CJ; Himelman E; Lahey KC; Zhao Q; Yehia G; Tao YX; Bhaumik M; Shirokova N; Fraidenraich D
Stem Cells; 2017 Mar; 35(3):597-610. PubMed ID: 27734557
[TBL] [Abstract][Full Text] [Related]
2. Blastocyst injection of wild type embryonic stem cells induces global corrections in mdx mice.
Stillwell E; Vitale J; Zhao Q; Beck A; Schneider J; Khadim F; Elson G; Altaf A; Yehia G; Dong JH; Liu J; Mark W; Bhaumik M; Grange R; Fraidenraich D
PLoS One; 2009; 4(3):e4759. PubMed ID: 19277212
[TBL] [Abstract][Full Text] [Related]
3. Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers.
Nouet J; Himelman E; Lahey KC; Zhao Q; Fraidenraich D
Sci Rep; 2020 Mar; 10(1):5683. PubMed ID: 32231219
[TBL] [Abstract][Full Text] [Related]
4. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
6. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.
Grady RM; Teng H; Nichol MC; Cunningham JC; Wilkinson RS; Sanes JR
Cell; 1997 Aug; 90(4):729-38. PubMed ID: 9288752
[TBL] [Abstract][Full Text] [Related]
7. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
[TBL] [Abstract][Full Text] [Related]
10. Phenotype of dystrophinopathy in old mdx mice.
Lefaucheur JP; Pastoret C; Sebille A
Anat Rec; 1995 May; 242(1):70-6. PubMed ID: 7604983
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
12. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
13. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
15. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
16. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
Merrick D; Stadler LK; Larner D; Smith J
Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
[TBL] [Abstract][Full Text] [Related]
17. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
[TBL] [Abstract][Full Text] [Related]
18. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
Berry SE; Andruszkiewicz P; Chun JL; Hong J
Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
[TBL] [Abstract][Full Text] [Related]
19. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]